MARKET

STE

STE

Steris Plc
NYSE

Real-time Quotes | Nasdaq Last Sale

225.94
+2.54
+1.14%
After Hours: 225.94 0 0.00% 16:07 05/20 EDT
OPEN
225.69
PREV CLOSE
223.40
HIGH
226.66
LOW
221.15
VOLUME
578.66K
TURNOVER
0
52 WEEK HIGH
255.93
52 WEEK LOW
188.10
MARKET CAP
22.62B
P/E (TTM)
94.36
1D
5D
1M
3M
1Y
5Y
Here's Why You Should Hold STERIS (STE) Stock in Your Portfolio
Investors are optimistic about STERIS (STE) due to its strong fiscal fourth-quarter results.
Zacks · 5d ago
STERIS (STE) Q4 Earnings Surpass Estimates, Gross Margin Rises
Robust performances across all four reporting segments drive STERIS' (STE) fiscal fourth-quarter revenues.
Zacks · 05/12 14:27
--Needham Lowers Price Target for STERIS to $248 From $263, Maintains Buy Rating
MT Newswires · 05/12 14:17
BRIEF-Steris Announces Results For Fiscal 2022 Fourth Quarter And Full Year
reuters.com · 05/11 22:32
Steris: Q4 Earnings Insights
Steris (NYSE:STE) reported its Q4 earnings results on Wednesday, May 11, 2022 at 04:30 PM. Here's what investors need to know about the announcement. Earnings Steris beat estimated earnings by 0.99%, reporting an EPS of $2.04 versus an estimate of $2.02.
Benzinga · 05/11 20:56
Steris Non-GAAP EPS of $2.04 beats by $0.02, revenue of $1.2B beats by $30M
Steris press release (NYSE:STE): Q4 Non-GAAP EPS of $2.04 beats by $0.02. Revenue of $1.2B (+37.4% Y/Y) beats by $30M. Outlook: For fiscal 2023, constant currency organic revenue growth is
Seekingalpha · 05/11 20:36
Steris Q4 EPS $2.04 Beats $2.02 Estimate, Sales $1.20B Beat $1.19B Estimate
Steris (NYSE:STE) reported quarterly earnings of $2.04 per share which beat the analyst consensus estimate of $2.02 by 0.99 percent. This is a 25.15 percent increase over earnings of $1.63 per share from the same period
Benzinga · 05/11 20:35
STERIS Announces Financial Results for Fiscal 2022 Fourth Quarter and Full Year
Fourth quarter revenue increases 39% as reported; 11% constant currency organicAs reported EPS of $0.52; adjusted EPS of $2.04Company provides FY23 outlook DUBLIN, IRELAND, May 11, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”)...
GlobeNewswire · 05/11 20:30
More
No Data
Learn about the latest financial forecast of STE. Analyze the recent business situations of Steris Plc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

40.00%Strong Buy
60.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average STE stock price target is 263.80 with a high estimate of 295.00 and a low estimate of 248.00.
High295.00
Average263.80
Low248.00
Current 225.94
EPS
Actual
Estimate
0.531.061.592.12
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Institutional Holdings
Institutions: 856
Institutional Holdings: 111.81M
% Owned: 111.67%
Shares Outstanding: 100.13M
TypeInstitutionsShares
Increased
235
5.75M
New
99
810.81K
Decreased
204
3.79M
Sold Out
64
1.01M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.35%
Healthcare Equipment & Supplies
+0.36%
Key Executives
Non-Executive Chairman/Independent Director
Mohsen Sohi
President/Chief Executive Officer/Director
Daniel Carestio
Chief Financial Officer/Senior Vice President
Michael Tokich
Senior Vice President/General Counsel/Secretary
John Zangerle
Vice President/Treasurer
Renato Tamaro
Vice President
Cary Majors
Independent Director
Richard Breeden
Independent Director
Cynthia Feldmann
Independent Director
Christopher Holland
Independent Director
Jacqueline Kosecoff
Independent Director
Paul Martin
Independent Director
Nirav Shah
Independent Director
Richard Steeves
No Data
No Data
About STE
STERIS plc is a provider of infection prevention and other procedural products and services. The Company offers a mix of consumable products, such as detergents, gastrointestinal (GI) endoscopy accessories, barrier product solutions, and other products and services, including: equipment installation and maintenance, microbial reduction of medical devices, dental instruments and tools, instrument and scope repair solutions, laboratory testing services, outsourced reprocessing, and capital equipment products, such as sterilizers and surgical tables, automated endoscope reprocessors, and connectivity solutions such as operating room (OR) integration. The Company operates through four reportable business segments: Healthcare, Applied Sterilization Technologies, Life Sciences and Dental. Its Healthcare segment focused on sterile processing departments and procedural centers, such as operating rooms, endoscopy suites, and renal dialysis centers.

Webull offers kinds of Steris PLC stock information, including NYSE:STE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, STE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading STE stock methods without spending real money on the virtual paper trading platform.